CClinicalTrials.gg
CompletedNCT02198534FELUpdated Nov 23, 2016

Comparison of the Freiburg Visual Acuity Test (FrACT) With the EDTRS- and Landoltring Charts

An observational study in Ophthalmologically Normal Subjects, sponsored by Schiefer Ulrich. Completed at 1 site in Germany. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-11-23.

Sponsored by Schiefer Ulrich · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
25
Ages
18 Years and older
Sex
All
01

Study summary

A) For the investigation of Visual acuity, inter-test agreement and the test-retest reliability were used three different visual acuity tests: ETDRS charts, Landoltring chart and Freiburg Visual Acuity Test (FrACt). The examinees passed each visual acuity test twice but the sequence of the visual acuity tests were randomize and so different for each examinee. The examinees were 24 adult Aalen university students (except students of ophthalmic optics in terms 2 - 7) with a minimal distant visual acuity without or with correction of 0.2. Another inclusion criteria was a maximum myopia of sph -2,00 dpt, a maximum hyperopia of sph +5,50 dpt and a maximum astigmatism of cyl 2,50 dpt. The Landolt C was projected in eight-orientations. For the FrACT Test we used two different devices for response input: a modified keypad with Landoltring symbols (FrACTk) and a haptic Landolt device with an adjustable Landoltring (FrACTh). The primary objective was the comparison between FrACTk and FrACTh. The secondary Objective contains the comparison between all visual acuity tests.

B) Background: Landolt Cs and letters are commonly used optotypes. In the explorative study we compare four different ways of applying them: The Freiburg visual acuity test (FrACT) using a keypad and a haptic Landolt device, a Landolt C chart in accordance to ISO 8596 and DIN 58220 with eight-orientated Landolt C and ETDRS charts. The aims of the survey were to determine examinee´s/examiner´s subjective ratings using Visual analogue scales (VAS), the inter-test agreement between the tests and test-retest reliability of the tests, concerning the test duration.

Subjects and Methods: Twenty-four adult examinees with a visual acuity of ≥ 0,2 were included in the explorative study. The visual acuity of one eye was measured monocularly, randomized with regard to the leading/non-leading eye. The subjects passed every visual acuity test twice in a randomized sequence of the visual acuity tests, which is maintained by a pre-specified randomization list, making use of forced choice.

Read the detailed description
  1. FrACT (internet version 3.8.1) 1.1 haptic Landolt Ring device (FrACTh) 1.2 modified keypad with Landolt Ring symbols (FrACTk)
  2. ETDRS Visual Acuity Tester (Steinbeis Transferzentrum Biomedizinische Optik, Tübingen/Germany)
  3. Landoltring chart (Visus GmbH, Stuttgart/Germany)
  4. VISUCAT monitor with single optotype display(numbers; Argus Individuell Optic GmbG, Putzbrunn/Germany)
  5. Room illuminance level 250 lx, assessed with digital luxmeter (Peak Tech 5025, Peak Tech Prüf - und Messtechnik GmbH, Ahrensburg/Germany)
  6. Laptopdisplay (TravelMate, Acer, 8372 Taipeh/China):

    luminance level 151 cd/m2 , surround luminance level 75 cd/m2 , assessed with luminance meter (IS-110 Laptop Minolta, Tokyo/Japan)

  7. ETDRS Visual Acuity Tester:

    luminance level: 237 cd/m², surround luminance level 85 cd/m²

  8. Landoltring Chart:

    luminance level: 236 cd/m², surround luminance level 84 cd/m²

  9. VISUCAT:

    luminance level: 380 cd/m², surround luminance level 70 cd/m²

  10. Stopwatch (Apple iPhone 4S, Cupertino CA/USA)
  11. Laser Rangefinder (GLM 80 Professional, Bosch GmbH, Stuttgart/Germany)
02

Conditions studied

  • Ophthalmologically Normal Subjects

Keywords

  • visual acuity
  • Landolt C
  • ETDRS charts
  • Freiburg Visual Acuity Test
  • FrACT
  • Comparison
  • acceptance
  • Test retest reliability
  • duration
  • questionnaire
03

In context

Lead sponsor

This is the only study on the registry with Schiefer Ulrich as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Ophthalmologically normal subjects

Inclusion criteria

  • age ≥ 18 years
  • Minimum distant visual acuity (without/with correction) 0.2 (Visucat, single letter optotypes [numbers], initial session). As long as minimum distant visual acuity limits are exceeded, test runs without optical corrections are preferred in order to enhance the spectrum/variety of tested visual acuity values
  • Ametropia:

maximum myopia sph -2.00 dpt maximum hyperopia sph +5.50 dpt maximum astigmatism cyl 2.5 dpt

  • informed consent

Exclusion criteria

Exclusion Criteria:

  • Epilepsy / psychiatric disorders
  • Drugs affect the reaction time and / or determining the visual acuity, or the refractive power of the eye
  • Ophthalmic Education
  • Amblyopia
  • strabismus
  • Glaucoma IOP> 22 mmHg
  • Nystagmus
  • Diabetic retinopathy (blood sugar-related retinal disease)
  • Very dry eyes (sicca symptoms)
  • eye surgery back are less than 3 months
  • Infectious diseases (conjunctivitis, corneal inflammation, choroidal inflammation)
  • miosis drugs
  • Pronounced eye injuries
  • Other eye disorders that affect the image quality
  • Macular diseases
  • albinism
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
25 participants (actual)
Patient registry
No
Biospecimen retention
None retained

Groups and cohorts

  • ophthalomogically normal subjects

    Device: Methodology of visual acuity assessment

Interventions

  • DeviceMethodology of visual acuity assessment

    Also known as: VISUCAT, FrACT, ETDRS Chart, Landolt C

06

What researchers measure

Primary outcomes

  1. A) 1.Visual acuity (in terms of spatial resolution)

    Comparison of visual acuity measurements, visualized by Bland-Altman plots

    Time frame: July - August, 2014 (1 month)

  2. Inter-test agreement between FrACTh and FrACTk with regard to visual acuity results

    Assessment of inter-test agreement between FrACTh and FrACTk by comparison between these two methods, visualized by Bland-Altman plots

    Time frame: July - August, 2014 (1 month)

  3. Test-retest reliability of FrACTh and FrACTk with regard to visual acuity results

    Assessment of test-retest reliability of FrACTh and FrACTk by repeated measurements, visualized by Bland-Altman plots

    Time frame: July - August, 2014 (1 month)

Secondary outcomes

  1. Examinees´ / examer's subjective ratings regarding the test procedures

    Assessment of examinees´ / examiner´s subjective ratings, using box \& whisker plots for analysis of the visual analogue scale (VAS) results

    Time frame: July - August, 2014 (1 month)

  2. Test duration (in seconds)

    Assessment of test duration and its comparison, using box \& whisker plots and/or Bland-Altman plots

    Time frame: July - August, 2014 (1 month)

07

Study locations

1 site
  • University of Applied Sciences, Study Course Ophthalmic Optics
    Aalen, Baden-Württemberg 73430, Germany
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 23, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02198534
Lead sponsor
Schiefer Ulrich
Responsible party
Schiefer Ulrich (Prof. Dr. med., Aalen University) — Sponsor-investigator
First posted
Jul 23, 2014
Start date
Jun 2014
Primary completion
Oct 2014
Completion
Jun 2015
Last update
Nov 23, 2016

Study contacts

Ulrich Schiefer, Prof. Dr. med.
principal investigator · University of Applied Sciences Aalen

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion